Results 31 to 40 of about 18,691 (198)

Metaplastic Squamous Cell Carcinoma of Breast-An Uncommon Tumor with an Unusual Presentation A Case Report

open access: yesJournal of Islamic International Medical College, 2021
Metaplastic breast carcinoma is uncommon. Pure Metaplastic squamous cell carcinoma is rare. Usually there is mixed type (adenosquamous) in which few areas show squamous metaplasia. The incidence has reported only 1 0.1 to 2%.
Javeria Faridi , Saeed Alam
doaj  

Imaging Findings of Metaplastic Breast Carcinoma with Chondroid Differentiation: A Case Reports

open access: yes대한영상의학회지, 2022
Metaplastic carcinoma of the breast is a heterogeneous group of neoplasms with mixed epithelial and mesenchymal differentiation. Metaplastic carcinoma of the breast is a rare and aggressive malignancy, with high recurrence and metastasis.
Ji-Young Kim   +6 more
doaj   +1 more source

Metaplastic breast cancer with chondroid differentiation [PDF]

open access: yesJournal of Community Hospital Internal Medicine Perspectives, 2015
Background: Metaplastic carcinoma of the breast is an extremely rare subtype of breast cancer with an incidence of
Zin W. Myint   +2 more
doaj   +1 more source

Targeted therapy combined with immunotherapy in patients with breast infiltrating ductal carcinoma with axillary lymph node metastasis of metaplastic SCC

open access: yesThoracic Cancer, 2022
At present, the clinicopathological features, optimal treatment patterns, and prognosis of breast metaplastic squamous cell carcinoma (SCC) are not fully understood and are still controversial.
Rilan Bai   +6 more
doaj   +1 more source

Metaplastic breast carcinoma with extensive osseous differentiation

open access: yesAutopsy and Case Reports, 2021
Metaplastic breast carcinoma is a rare subtype of invasive breast carcinoma. Metaplastic carcinoma with osseous differentiation is exceptionally uncommon.
Shalaka Khade   +3 more
doaj  

Metaplastic breast carcinomas are basal‐like tumours [PDF]

open access: yesHistopathology, 2006
Aims : Recently, an immunohistochemical panel comprising antibodies against HER2, oestrogen receptor (ER), epidermal growth factor receptor (EGFR) and cytokeratin (CK) 5/6 was reported to identify basal‐like breast carcinomas, as defined by cDNA microarrays.
Reis-Filho, J. S.   +8 more
openaire   +4 more sources

Metaplastic breast carcinoma “fibromatosis like”, associated with intraductal papilloma. Case report and literature review

open access: yesHuman Pathology: Case Reports, 2017
The “fibromatosis like” phenotype is a rare tumor and represents just 1% of breast carcinomas. It is classified into a large group of heterogeneous metaplastic carcinomas.
Ignacio Pinilla Pagnon   +9 more
doaj   +1 more source

Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma

open access: yesBreast Cancer Research, 2023
Background Metaplastic breast carcinoma (MpBC) typically consists of carcinoma of no special type (NST) with various metaplastic components. Although previous transcriptomic and proteomic studies have reported subtype-related heterogeneity, the intracase
Huang-Chun Lien   +8 more
doaj   +1 more source

Metaplastic Carcinoma of the Breast

open access: yesArchives of Pathology & Laboratory Medicine, 2015
Metaplastic carcinoma of the breast is a rare but aggressive type of breast cancer that has been recognized as a unique pathologic entity by the World Health Organization. Morphologically, it is characterized by the differentiation of neoplastic epithelium into squamous cells and/or mesenchymal-looking elements (squamous cells, spindle cells, cartilage
Elizabeth, McKinnon, Philip, Xiao
openaire   +2 more sources

Histochemical Study of Inflammatory Lesions of Gall Bladder with Reference to Metaplastic Conditions [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2018
Introduction: Cholelithiasis and asymptomatic gallstones may produce pathological changes like hyperplasia and metaplasia of the gall bladder mucosal epithelium.
Biparnak Haldar   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy